RxDoctor Payments Data

David Lu, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1073542668

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $86,335 of the $112,728 with a category attached, or 76.6%. Medical Device Business Services, Inc. accounts for 95.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $80,738 and has fallen 96.4% since, to $2,928 in 2025. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,728in general payments, 2019–2025

Across 55 payments — averaging $2049.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$107K
  • Histosonics, Inc.$2K
  • Johnson & Johnson$1K
  • Galvanize Therapeutics, Inc$465
  • Boston Scientific$397
  • Siemens Medical Solutions USA, Inc.$267
  • plus $581 from 6 others
$58,972in research payments, 2019–2025

Across 6 payments — averaging $9828.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insightec,ltd$59K

What the payments were for

  • Consulting fees$86,33577%
  • Travel & lodging$23,69221%
  • Food & beverage$2,7012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$112,728 in reported general payments places this provider in the 90th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$339,922
Medicare patients
1,050
Services billed
35,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl12$44

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →